In today’s briefing:
- Taiwan Tech Weekly: TSMC’s Latest Sub-Industry Guidance; PC Names Strong; Computex & Apple WDC Ahead
- Vanguard (5347.TT): Planning to Announce the Construction of a 12″ Fab in Singapore in 2024.
- China Healthcare Weekly (May.26)-VBP Scope Expands, Optimistic About Glove Industry, China Resources
- Baidu: Priced to Fail
- Monthly Container Shipping Tracker | Pricing Still Firm | Share Prices Converging | (May 2024)
- China Consumption Weekly (27 May 2024): Xpeng, Tongcheng, Kanzhun, Gaotu, KE, Bilibili, and Weibo
- Icici Securities (NSE:ISEC) – Sunday, Feb 25, 2024
- Pluxee (PLX.PA) – Sunday, Feb 25, 2024
- Warby Parker Inc (WRBY) – Friday, Feb 23, 2024
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
Taiwan Tech Weekly: TSMC’s Latest Sub-Industry Guidance; PC Names Strong; Computex & Apple WDC Ahead
- TSMC’s Latest 2024E Industry Guidance Provided at Symposium in Taiwan
- More Potential Details on Nvidia & Mediatek’s AI PC Chip to Compete with Qualcomm & Intel
- Samsung’s HBM DRAM Chips Face Challenges in Meeting Nvidia’s AI Requirements
Vanguard (5347.TT): Planning to Announce the Construction of a 12″ Fab in Singapore in 2024.
- Vanguard should declare to established 12″ Fab in Singapore within 2014.
- Vanguard is likely to announce the establishment of 2 sets of 12″ fabs in the next 6 months.
- China is expanding 28/22nm and above technologies, and we believe it’s more appropriate for Vanguard to compete with others rather than TSMC.
China Healthcare Weekly (May.26)-VBP Scope Expands, Optimistic About Glove Industry, China Resources
- The NHSA issued a Notice on “improving the quality and expanding the scope of VBP”. The trend of full coverage of VBP of conventional drugs/consumables is determined.TCM is under pressure.
- We analyzed the potential demand growth rate of the glove industry, which is already better than most cyclical stocks. Therefore, we see no need to remain pessimistic about this industry.
- Holding platform companies have valuation discounts.HK$50-60 billion is reasonable market value for China Resources Pharmaceutical.Better to go long when share price is below HK$5 and then hold to receive dividends.
Baidu: Priced to Fail
- Since late 2020, Search’s share of digital advertising revenue has stabilised at around 8-10%, seemingly retaining its core advertising customers and industries.
- Baidu management expects AI Cloud to maintain strong revenue growth momentum in the upcoming quarters.
- Baidu trades on a 3.6x NTM EV/EBITDA multiple, well below one standard deviation lower than its 5-year historical average trading range and the lowest it has ever been.
Monthly Container Shipping Tracker | Pricing Still Firm | Share Prices Converging | (May 2024)
- Our index shows April pricing momentum remained positive in deep-sea trades
- Evergreen Marine posted strong revenue and earnings growth in Q124
- Container carriers have performed well YTD in 2024; we expect convergence
China Consumption Weekly (27 May 2024): Xpeng, Tongcheng, Kanzhun, Gaotu, KE, Bilibili, and Weibo
- In 1Q24, Revenues of Xpeng, Tongcheng, Kanzhun, and Gaotu grew by 62% YoY, 50%, YoY, 43% YoY and 34% YoY.
- KE’s revenue decreased by 20% YoY in 1Q24 due to the weak property market.
- Bilibili’s value added services revenue grew by 17% YoY and advertising revenue grew by 31% YoY.
Icici Securities (NSE:ISEC) – Sunday, Feb 25, 2024
- Recommendation to buy ISEC shares at Rs 840 per share with a price target of Rs 1200 per share
- Dissatisfaction among minority shareholders due to insider’s attempt to acquire remaining shares at a lower price
- Illiquidity and limited institutional investors due to Parent owning 75% of shares, potential merger poses a risk but shareholders can extract fair value even in a merger scenario
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.
Pluxee (PLX.PA) – Sunday, Feb 25, 2024
- Pluxee is a spin-off company with a strong business model, offering an attractive investment opportunity.
- The company’s undervalued stock price and potential for growth make it a compelling choice for investors.
- With large insider ownership, new initiatives, and the Bellon family as controlling shareholders, Pluxee is expected to see improvements and long-term success.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.
Warby Parker Inc (WRBY) – Friday, Feb 23, 2024
- Warby Parker disrupted the eyewear industry in 2010 with affordable prices and innovative styles, known for their commitment to social impact
- The company has faced challenges with slowing growth and increased competition, leading to concerns about its uniqueness and disrupter status
- Critics believe that Warby Parker’s focus on technology and business model changes indicate a potential decline, making it a target for short selling.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.